Adjuvanted vaccine boosts flu protection for elderly

October 16, 2013 by Camilo Mejia Giraldo
Researchers analysed a demographic that has increasing issues with their immune system’s response to vaccines. Credit: BromfordGroup

A recent study has strengthened the current knowledge of the increased effectiveness of adjuvanted flu vaccines in the elderly—a population highly affected by seasonal influenza.

Adjuvants are substances that can be added to vaccines to aid the body's immune response to the .

The 'real world' study, based in Canada, assessed less than 300 elderly for adjuvanted .

It found an MF59 adjuvanted vaccine provided more protection (60 per cent effectiveness) against compared with the unadjuvanted trivalent influenza vaccine.

"We've seen data before that said if you just measure [the patient's] blood anti-body levels, it shows that they do better with the adjuvanted [vaccines]," says Dr Paul Van Buynder, a UWA appointee and co-author of the study.

"What we weren't sure of was whether that would turn into better protection against actual flu, and that is what we were looking at," he says.

Researchers contacted people over 65 years-old who had been routinely lab tested after they had exhibited influenza-like symptoms.

"We have different polices in different parts of British Columbia, some clinics give the adjuvanted vaccines and some do not, so the study was a natural experiment," he says.

After the participants were interviewed, their vaccination status, date and type were confirmed through healthcare records.

Dr Van Buynder says even though adjuvanted vaccines are known to have superior effects, researchers of the study were pleased at the positive results showed by MF59—which is a oil-in-water adjuvant containing a shark oil derivative and two surfactants.

With participants of the study at a median age of 83 years, researchers analysed a demographic that has increasing issues with their immune system's response to vaccines.

"It's a thing called immunosenescence, the older you get, the worse your white cells produce anti-bodies," he says.

"This is a new generation of adjuvants … it actually has an impact on stimulating the antigen production cells, particularly the dendritic cells in the skin area, so they bring a lot more antibodies across to where the vaccine has been administered."

Dr Van Buynder says adjuvanted vaccines are widely used throughout Canada and the EU, but not in the United States or Australia—although some adjuvanted vaccines are licensed in Australia.

"We were looking at what whether in the real world it actually made a difference," he says.

"Because it's one thing to look at the blood levels in a lab and what we wanted to say is that this actually produces a difference."

Explore further: No substantial link between swine flu vaccine and Guillain-Barre syndrome, confirm experts

More information: www.sciencedirect.com/science/ … ii/S0264410X13010451

Related Stories

No substantial link between swine flu vaccine and Guillain-Barre syndrome, confirm experts

July 13, 2011
Adjuvanted vaccines used during the 2009 swine flu pandemic did not increase the risk of Guillain-Barré syndrome substantially, if at all, finds a large Europe-wide study published in the British Medical Journal today. ...

New development could increase flu vaccine supply

June 2, 2011
(Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed a new adjuvant, or compound ...

New research finds flu shot effective regardless of circulating flu strain

June 25, 2013
New research out of St. Michael's Hospital has found that despite popular belief, the flu shot is effective in preventing the flu, even if the virus going around does not match the vaccine.

Mayo Clinic expert explains new vaccine options for next influenza season

July 16, 2013
The next flu shot season will include several new vaccine options for consumers, Mayo Clinic vaccine expert Gregory Poland, M.D., says. Fearful of needles? There's now an influenza vaccination just for you. Allergic to eggs? ...

Some flu vaccines promise a little more protection

September 2, 2013
It's time to get your flu vaccine, and this fall some brands promise a little extra protection.

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.